| USDA
Press Release
CHROMIUM
SUPPLEMENTS MAY BE BENEFICIAL FOR DIABETICS
San Francisco, CA (June 9, 1996)- People
in China with type II diabetes had marked reductions
in their blood sugar and insulin levels after two to
four months of taking chromium picolinate supplements.
And the most sensitive measure of diabetic control-hemoglobin
A(ic)-dropped to normal, according to a U.S. Depar™ent
of Agriculture study presented June 9 at the annual
scientific meeting of the American Diabetes Association.
Chromium expert Richard Anderson of USDA's Agricultural
Research Service said that "the results are preliminary
and need to be reproduced in the United States before
chromium can be recommended for the trea™ent of diabetes.
But they're better than we had hoped for. Even those
getting 200 micrograms (mcg) of chromium daily improved
in several indices of diabetes." That's the upper
limit of the estimated safe and adequate intake.
In the U.S., it's possible that people with diabetes
would need higher levels of chromium to realize similar
improvements because Americans are larger than the Chinese
and eat more fat and sugar. All of these factors raise
the requirement for chromium. "No other studies
have seen consistent improvements with 200 mcg."
He noted that some people with diabetes won't respond
to chromium supplements at all for reasons that are
still unclear.
Anderson and Nanzheng Cheng, a physician, spearheaded
the four-month study. Cheng--a former visiting scientist
in Anderson's laboratory--and her sister Nanping Cheng,
a physician in Beijing--recruited 180 people with type
II diabetes through three Beijing hospitals and assigned
them to three groups of 60 each. All of them produced
insulin; none was in an advanced stage of the disease.
One group got 100 mcg of chromium as chromium picolinate
at two different times each day, while a second group
got 500 mcg twice daily. Dividing the supplement into
two doses allows the body to absorb more, Anderson explained,
because the two don't saturate the system as much as
a single dose. A third group got look-alike placebos.
To ensure objectivity in the study, neither the volunteers
nor the researchers knew who got which capsules.
The volunteers getting a total of 1000 mcg--or one milligram
(mg)--daily improved significantly compared to the placebo
group after only two months, Anderson said. By the end
of four months, their average hemoglobin A(ic) was 6.6
percent compared to 8.5 for the placebo group. A normal
level is usually less than 6.2 percent. The value is
a measure of how much hemoglobin has sugar bound to
it he said. It's considered the "gold standard"
of diabetes tests.
The low-chromium group--those volunteers getting a total
of 200 mcg daily-ended the study with a hemoglobin A(ic)
level of 7.5 percent--also significantly below the placebo
group. But there was no significant difference in blood
glucose between the low-chromium and placebo groups.
In the high-chromium group, however, blood glucose after
an overnight fast was down to 129 milligrams per decaliter
(mg/dL) versus 160 mg/dL in the placebo group. And it
averaged 190 mg/dL two hours after eating a meal versus
223 mg/dL in the placebo group. In nondiabetic people,
blood glucose is around 100 mg/dL after fasting and
120 mg/dL after a meal, said Lois Jovanovic-Peterson,
a physician specializing in diabetes and a senior scientist
at the Sansum Medical Research Foundation in Santa Barbara,
Calif.
"These are improvements to the level of good control,"
she said. "It's as good as what we currently have
available--oral hypoglycemic agents, diet and exercise.
If further research confirms these numbers, chromium
supplements could be an add-on therapy to current trea™ents
to further lower blood glucose."
In addition to improvements in blood glucose, the high-chromium
group had a significant drop in total cholesterol. And
both the high- and low-chromium groups had a significant
drop in plasma insulin just two months after beginning
the supplements and a further drop at four months. People
with type II, or maturity-onset, diabetes produce more
insulin than normal in the early stages of the disease,
Anderson explained, because the hormone is less efficient
at clearing glucose from the blood. Chromium apparently
makes the hormone more efficient.
"We controlled diabetes with a nutrient--given
at higher levels than can be gotten from the diet,"
said Anderson. He said people with type II diabetes
absorb more chromium. But they also excrete more, so
their tissue levels are lower, indicating that the body
has trouble using what it absorbs.
Anderson also said he has maintained rats on daily doses
of chromium picolinate or an inorganic form of the mineral
several thousand times above the highest suggested intake
for humans with no adverse effects on the sensitive
organs.
There is no Recommended Dietary Allowance for chromium.
The estimated safe and adequate dietary intake is between
50 and 200 mcg daily. Most Americans consume less than
50 mcg, Anderson said. He has analyzed well-balanced
diets prepared by dietitians and found them to contain
only about 33 mcg per day.
<<<back
Copyright, 2003 - 2009 DHS, Inc. All Rights Reserved.
Reproduction of any kind is prohibited without the written permission of DHS, Inc.
|